Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.
Terpos E, Mougiou A, Kouraklis A, Chatzivassili A, Michalis E, Giannakoulas N, Manioudaki E, Lazaridou A, Bakaloudi V, Protopappa M, Liapi D, Grouzi E, Parharidou A, Symeonidis A, Kokkini G, Laoutaris NP, Vaipoulos G, Anagnostopoulos NI, Christakis JI, Meletis J, Bourantas KL, Zoumbos NC, Yataganas X, Viniou NA; Greek MDS Study Group. Terpos E, et al. Among authors: viniou na. Br J Haematol. 2002 Jul;118(1):174-80. doi: 10.1046/j.1365-2141.2002.03583.x. Br J Haematol. 2002. PMID: 12100145 Free article. Clinical Trial.
Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor.
Diamantopoulos PT, Chatzileonida T, Galanopoulos A, Yiakoumis X, Saridaki AM, Angelidis A, Papakostas E, Bazanis E, Sachanas S, Michael M, Pangalis GA, Anagnostopoulos NI, Meletis J, Viniou NA. Diamantopoulos PT, et al. Among authors: viniou na. Leuk Lymphoma. 2012 Oct;53(10):2069-72. doi: 10.3109/10428194.2012.668679. Epub 2012 Apr 9. Leuk Lymphoma. 2012. PMID: 22360720 No abstract available.
Correlation of Fc-γ RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas.
Diamantopoulos PT, Kalotychou V, Polonyfi K, Sofotasiou M, Anastasopoulou A, Galanopoulos A, Spanakis N, Vassilakopoulos T, Angelopoulou M, Siakantaris M, Variami E, Poziopoulos C, Terpos E, Kollia P, Viniou NA. Diamantopoulos PT, et al. Among authors: viniou na. Leuk Lymphoma. 2013 Sep;54(9):2030-4. doi: 10.3109/10428194.2012.762512. Epub 2013 Jan 23. Leuk Lymphoma. 2013. PMID: 23270585
Cessation of tyrosine kinase inhibitors in patients with chronic-phase chronic myelogenous leukemia following durable complete molecular response: a single center facing the dilemma.
Iliakis T, Papadopoulou V, Diamantopoulos PT, Panayiotidis P, Zervakis K, Giannakopoulou N, Tilimidos G, Angelopoulou M, Siakantaris MP, Pangalis G, Mantzourani M, Variami E, Viniou NA. Iliakis T, et al. Among authors: viniou na. Anticancer Res. 2013 Aug;33(8):3509-14. Anticancer Res. 2013. PMID: 23898127
Evidence for regulation of oxidative stress by latent membrane protein 1 oncoprotein in patients with low-grade leukemic B cell lymphoma with latent Epstein-Barr virus infection.
Papadopoulou V, Diamantopoulos PT, Kontandreopoulou E, Polonyfi K, Variami E, Kouzis P, Galanopoulos A, Spanakis N, Zervakis K, Iliakis T, Perrea D, Kollia P, Vassilakopoulos TP, Pangalis GA, Kyrtsonis C, Vaiopoulos G, Viniou NA. Papadopoulou V, et al. Among authors: viniou na. Leuk Lymphoma. 2014 Aug;55(8):1904-9. doi: 10.3109/10428194.2013.867487. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24261679
117 results